Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Arachidonic Acid and Dinoprostone

Research Papers that Mention the Interaction

Moreover, the gene expression levels of EP4 and FP, the respective prostanoid receptors for PGE2 and PGF2α, were gradually suppressed by the supplementation with AA , whereas that of IP for PGI2 remained relatively constant.
The treatment of cultured preadipocytes with AA resulted in the decreased synthesis of PGE2 and PGF2α serving as anti-adipogenic PGs although the biosynthesis of pro-adipogenic PGI2 was up-regulated during the differentiation phase.
Prostaglandins & other lipid mediators  •  2016  |  View Paper
Isoproterenol and PGE2 appear thus to enhance arachidonic acid-induced platelet aggregation after interacting with different receptor sites.
Agents and Actions  •  2005  |  View Paper
Release of prostaglandin E2 was elevated only with supplementation of AA.
Pediatric Research  •  2002  |  View Paper
Prostaglandin E2 production by tumour cells was increased in the presence of arachidonic acid and inhibited when indomethacin was present.
Biochemistry and molecular biology international  •  1998  |  View Paper
The substance has been shown to modulate arachidonic acid metabolism by enhancing the production and release of prostacyclin and prostaglandin E2 from tissues and whole blood, and inhibiting leukotriene B4 generation in leukocytes.
Seminars in thrombosis and hemostasis  •  1996  |  View Paper
The addition of AA (10 to 100 microM) increased both PGE2 and PGF2 alpha release, and simultaneously overcame the inhibition of PGE2 but not PGF2 alpha release by BETA.
Placenta  •  1993  |  View Paper
PGE2 synthesis was increased by supplementation of the medium with arachidonic acid (2.6 microM), whereas indomethacin (5.6 microM) had the opposite effect.
Molecular and chemical neuropathology  •  1992  |  View Paper
From the results of the latter studies, we suggest that endogeneously released arachidonic acid could account for some of the reduction in PGE2 binding.
Endocrinology  •  1985  |  View Paper
AA supplementation triggered the synthesis and secretion of PGE2 in ASA‐treated CGCS (p < .05).
Molecular reproduction and development  •  2020  |  View Paper
Arachidonic acid with fatty acid-free albumin significantly enhanced the release of PGE2 into the medium in a concentration-dependent manner.
Biochemical and biophysical research communications  •  2020  |  View Paper
Show More